Modules
Copperfield Laboratory Partners, Corp.
Customer 44663
- Account Classification
- Physician-Office Laboratory
- Classification Confidence
- High
- Sites
- HQ
- Assigned Reps
- Raymond Sutter
- Website
- —
- Active Opportunity Count
- 12
- Published Count
- 7
- Revenue Base
- 17700.07
- Known GPBase
- 13120.810000000001
- Analyzer Platforms
- Beckman Access / DxI | Olympus / Beckman AU
- Product Groups
- Beckman Access | Olympus
- Recommended Contact
- Noah Lofgren
- Backup Contact
- Dana Ashcombe | Lab Tech | dana.ashcombe@copperfieldlaboratorypartnerscorp.com
- Last Meaningful Activity
- 2019-09-13
- Customer Memory
- AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Beckman Access / DxI. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Beckman Access / DxI. Verified item fact: storage requirement N/A. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-66c3a89df4edd43c336c4a16451962b2c615f454eb065a125aa1491b08c2235c | Customer 44663 | Candidate CAND-ae59a2ca342dfa81906cd874a3118b642aaab04a55f6ec5702485f1b2a5b7ba9 | Customer 44663 | Order 50655 | Item 10920 | Candidate CAND-7998a6704b755251830e52ea2b7c74eb68d6958239c9ba8d24afd293bc75bc48 | Customer 44663 | Order 50655 | Item 9233 | Candidate CAND-ab1d312c9b43f90c698bb5ea3a84fc1fdaef0666e72f4461c9a4224bdd5ccc0c | Customer 44663 | Order 50528 | Item 4877 | Candidate CAND-9e2de452c082344e13d25987ee35f28539e03cc9791874d5d028540d7b616518 | Customer 44663 | Order 50655 | Item 5298 | Candidate CAND-510a181ba4960888fb242be2a0c560ecc79504ec411974884a6d17f58c261ddb | Customer 44663 | Order 50528 | Item 5240 | Candidate CAND-f68e0d2eff949adc74886fa0784972ce3111620794333b6891f6655acf915861 | Customer 44663 | Order 50528 | Item 4880
Opportunities (17)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-66c3a89df4edd43c336c4a16451962b2c615f454eb065a125aa1491b08c2235c | OPP-a97460db2218dc60f374f2cc0b036b23cc9ae6bb7233a6521f77342108a5928b | SER-ac9b82f1b5ffdaffd1e99a553d724b4eec3df39601d655efcfa5eba4853cde5c | Published | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue and Gross-Profit Decline; 2 independent signals; trailing 90-day revenue $11563.03 versus $13914.16; trailing 180-day revenue $25477.19 versus $55643.04; -3 days beyond expected account order date. | 7541.46 | 15082.92 | 22624.39 | 5495.3 | 10990.61 | 16485.91 | 79.81 | High | False | True | — | CALL | Candidate CAND-66c3a89df4edd43c336c4a16451962b2c615f454eb065a125aa1491b08c2235c | Customer 44663 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ae59a2ca342dfa81906cd874a3118b642aaab04a55f6ec5702485f1b2a5b7ba9 | OPP-e0444953ec1f905b91840e666ca552b3af8fdd78b14e4eaa68931eeb510bbfef | SER-30b683e6804b1eff35532034e38cdd772d6d774c4415f95f848ca4c1033507e2 | Published | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | B24838 | B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests | — | 50655 | 11 completed purchases over 308 days; median interval 22.5 days; expected reorder 2026-03-30; High Risk by 133 days. | 775 | 1033.33 | 1291.67 | 662.63 | 883.5 | 1104.38 | 76.07 | Medium | False | False | — | CALL | Candidate CAND-ae59a2ca342dfa81906cd874a3118b642aaab04a55f6ec5702485f1b2a5b7ba9 | Customer 44663 | Order 50655 | Item 10920 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7998a6704b755251830e52ea2b7c74eb68d6958239c9ba8d24afd293bc75bc48 | OPP-8ba3932606a4df8067734c98d98d62ed32cfbf1911780b415cf5724c13e7edb1 | SER-7115527e3e2a51e36ba05e356de00546f678c130ed870d8641b33c0a2e4bdd48 | Published | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | C71762 | C71762 (previously 33860) Beckman Access Thyroglobulin Reagent, 100 Determinations, 2 x 50 tests | — | 50655 | 18 completed purchases over 374 days; median interval 17.0 days; expected reorder 2026-03-20; High Risk by 143 days. | 397.95 | 530.6 | 663.25 | 353.7 | 471.6 | 589.5 | 72.85 | Medium | False | False | — | CALL | Candidate CAND-7998a6704b755251830e52ea2b7c74eb68d6958239c9ba8d24afd293bc75bc48 | Customer 44663 | Order 50655 | Item 9233 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ab1d312c9b43f90c698bb5ea3a84fc1fdaef0666e72f4461c9a4224bdd5ccc0c | OPP-8540ac9a34c1082d371bc8588199b25a52dfb117fc1764f58b5d7f2e0dbe59b8 | SER-6a4d2f466c85ae39113007a86e4b66a14922c2ded0c391928e69608ade1f70fd | Published | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | 81906 | 81906 Beckman Access Substrate | — | 50528 | 11 completed purchases over 350 days; median interval 30.5 days; expected reorder 2026-03-23; High Risk by 140 days. | 281.25 | 375 | 468.75 | 285 | 380 | 475 | 72.75 | Medium | False | False | — | CALL | Candidate CAND-ab1d312c9b43f90c698bb5ea3a84fc1fdaef0666e72f4461c9a4224bdd5ccc0c | Customer 44663 | Order 50528 | Item 4877 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9e2de452c082344e13d25987ee35f28539e03cc9791874d5d028540d7b616518 | OPP-f1073f549643f7d7897b783c4e66c7606fb4ccbc1bef141fdd73d9d35b5586e9 | SER-41c31552a23148e8e6e9b17c2d6491f9bd49a0d88a3b147d9bf75a69d3ad22d2 | Published | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | A12985 | A12985 TPO Antibody, Access, 2 x 50 tests | — | 50655 | 20 completed purchases over 374 days; median interval 14.0 days; expected reorder 2026-03-24; High Risk by 139 days. | 243.75 | 325 | 406.25 | 199.5 | 266 | 332.5 | 69.24 | Medium | False | False | — | CALL | Candidate CAND-9e2de452c082344e13d25987ee35f28539e03cc9791874d5d028540d7b616518 | Customer 44663 | Order 50655 | Item 5298 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-510a181ba4960888fb242be2a0c560ecc79504ec411974884a6d17f58c261ddb | OPP-77a7fe704fdd2e1fc0e8e7e24b6e55a752ab2f98eab59c43c87feb8773abc60d | SER-efc3028813a956643312959cfe1fa094fb06446933a3a494eab92f8d592aec92 | Published | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | A16953 | A16953 Beckman Access Intact PTH Calibrators (S0-S5, RB), 1 set, S0-S5 - 1.0 mL, RB - 2 x 4.0 mL | — | 50528 | 11 completed purchases over 359 days; median interval 29.5 days; expected reorder 2026-03-25; High Risk by 138 days. | 139.76 | 186.34 | 232.93 | 62.51 | 83.34 | 104.18 | 65.31 | Medium | False | False | — | CALL | Candidate CAND-510a181ba4960888fb242be2a0c560ecc79504ec411974884a6d17f58c261ddb | Customer 44663 | Order 50528 | Item 5240 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f68e0d2eff949adc74886fa0784972ce3111620794333b6891f6655acf915861 | OPP-723d1f3779227920f88b946befd920c2edf92da71b2f086016c736dfdf715155 | SER-34d2004cc4829e9ffd4d8ddb6dd75821c4692439dffc4d75a618b46508ccca7d | Published | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | 81901 | 81901 Beckman Access Cuvette Reaction Vessels | — | 50528 | 15 completed purchases over 364 days; median interval 21.5 days; expected reorder 2026-03-14; High Risk by 149 days. | 125.16 | 166.88 | 208.6 | 34.32 | 45.76 | 57.2 | 64.91 | Medium | False | False | — | CALL | Candidate CAND-f68e0d2eff949adc74886fa0784972ce3111620794333b6891f6655acf915861 | Customer 44663 | Order 50528 | Item 4880 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ef3975523eb49942bf49499b79304838bcfc6e25c9202dad4eec1faa1d912c4d | OPP-42a3622d5ab3347e0619b4e83b24615917094101c13d11c90fbaa60a7365f523 | SER-74ffefcf3af57d04d0d6303563057c89545606418a49a120c3cc394c34b4aa7f | Needs Validation | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6189 | Olympus OSR6189 MAGNESIUM REAGENT (4x250 tests) | — | 53149 | 12 completed purchases over 523 days; median interval 33.0 days; expected reorder 2026-08-26; Due Soon in 16 days. | 219.89 | 293.18 | 366.48 | 201.14 | 268.18 | 335.23 | 61.86 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-ef3975523eb49942bf49499b79304838bcfc6e25c9202dad4eec1faa1d912c4d | Customer 44663 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-aaa8dccbaf2e992bb4650ff201d1249e30bd4483f9dc9cdd7632aeff14a06b3d | OPP-c0a85ea36f942d57b4886f75e1d13078659e7276267450d6b19687b84fb565ad | SER-00e96bcce44237c59cb42f2ec50194fa73cd2ab830331f4c065dde6337b3f3f9 | Needs Validation | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | 33885 | 33885 Beckman Access FREE T4 CAL | — | 49833 | 4 completed purchases over 249 days; median interval 81.0 days; expected reorder 2026-03-27; High Risk by 136 days. | 115.34 | 153.78 | 192.23 | 83.69 | 111.58 | 139.48 | 59.25 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-aaa8dccbaf2e992bb4650ff201d1249e30bd4483f9dc9cdd7632aeff14a06b3d | Customer 44663 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5e6d408f0b542a207e34ef3c07ad258515f516d68af80fd02ad505ba49bffcfc | OPP-bde98fe574d0e0b227282a02ee4ddafc65f39f596642ff15640c4b39c8adc45f | SER-aa566ff58196f262aa87e2384d43afa61c831778236a01c071b6dd8c2d7428e5 | Needs Validation | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR6178 | Olympus OSR6178 CREATININE Reagent (4x990 tests) | — | 53149 | 11 completed purchases over 523 days; median interval 29.5 days; expected reorder 2026-08-24; Due Soon in 14 days. | 222.2 | 296.27 | 370.34 | 171.32 | 228.42 | 285.53 | 57.94 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-5e6d408f0b542a207e34ef3c07ad258515f516d68af80fd02ad505ba49bffcfc | Customer 44663 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c9addcd48778b1ee99a7fb76b2efa5ad95bd581f43b29d538ccb87e8eb0ef6a6 | OPP-7600dc623b17b6c4b94951f111f8fb05aee8b292ed9ffacc2f82148d5bf43c6a | SER-4226f1321281b926921bf753bdb53faf54fc121c4378d870eee7f18a25812ec8 | Needs Validation | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Beckman Access / DxI | Beckman Access | B24839 | B24839 Access 25(OH) Vitamin D Calibrators (for use on Access 2 Immunoassay Systems) (S0-S5) | — | 50212 | 3 completed purchases over 221 days; median interval 110.5 days; expected reorder 2026-05-17; High Risk by 85 days. | 132 | 176 | 220 | 68.25 | 91 | 113.75 | 55.6 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-c9addcd48778b1ee99a7fb76b2efa5ad95bd581f43b29d538ccb87e8eb0ef6a6 | Customer 44663 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-353d6df8208aaf3acffdb2fab8f690bdb7d7196a57c1e9b924aed261b5d56c09 | OPP-cea5b243216c2b543f8ba62adf06294c4f45c0ac2ac03b9bb131ba3da3bb3dd6 | SER-2c96947ff24e58732f432df6cd62e910e373e6853d0fdf0950ce023782ffe0eb | Needs Validation | **** | **** | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | Astoria | NY | Northeast | Physician-Office Laboratory | High | Olympus / Beckman AU | Olympus | OSR60118 | OSR60118 Triglycerides reagent 4x20/4x5mL 4/Kt | — | 52667 | 6 completed purchases over 409 days; median interval 67.0 days; expected reorder 2026-09-09; Due Soon in 30 days. | 146.25 | 195 | 243.75 | 102.71 | 136.95 | 171.19 | 51.81 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-353d6df8208aaf3acffdb2fab8f690bdb7d7196a57c1e9b924aed261b5d56c09 | Customer 44663 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ef3975523eb49942bf49499b79304838bcfc6e25c9202dad4eec1faa1d912c4d | OPP-42a3622d5ab3347e0619b4e83b24615917094101c13d11c90fbaa60a7365f523 | SER-74ffefcf3af57d04d0d6303563057c89545606418a49a120c3cc394c34b4aa7f | — | **** | — | — | Copperfield Laboratory Partners, Corp. | 44663 | HQ | — | NY | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 12 completed purchases over 523 days; median interval 33.0 days; expected reorder 2026-08-26; Due Soon in 16 days. | — | 293.18 | — | — | 268.18 | — | 61.86 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-ef3975523eb49942bf49499b79304838bcfc6e25c9202dad4eec1faa1d912c4d | Customer 44663 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-aaa8dccbaf2e992bb4650ff201d1249e30bd4483f9dc9cdd7632aeff14a06b3d | OPP-c0a85ea36f942d57b4886f75e1d13078659e7276267450d6b19687b84fb565ad | SER-00e96bcce44237c59cb42f2ec50194fa73cd2ab830331f4c065dde6337b3f3f9 | — | **** | — | — | Copperfield Laboratory Partners, Corp. | 44663 | HQ | — | NY | — | — | — | Beckman Access / DxI | — | — | — | — | — | 4 completed purchases over 249 days; median interval 81.0 days; expected reorder 2026-03-27; High Risk by 136 days. | — | 153.78 | — | — | 111.58 | — | 59.25 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-aaa8dccbaf2e992bb4650ff201d1249e30bd4483f9dc9cdd7632aeff14a06b3d | Customer 44663 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5e6d408f0b542a207e34ef3c07ad258515f516d68af80fd02ad505ba49bffcfc | OPP-bde98fe574d0e0b227282a02ee4ddafc65f39f596642ff15640c4b39c8adc45f | SER-aa566ff58196f262aa87e2384d43afa61c831778236a01c071b6dd8c2d7428e5 | — | **** | — | — | Copperfield Laboratory Partners, Corp. | 44663 | HQ | — | NY | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 11 completed purchases over 523 days; median interval 29.5 days; expected reorder 2026-08-24; Due Soon in 14 days. | — | 296.27 | — | — | 228.42 | — | 57.94 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-5e6d408f0b542a207e34ef3c07ad258515f516d68af80fd02ad505ba49bffcfc | Customer 44663 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c9addcd48778b1ee99a7fb76b2efa5ad95bd581f43b29d538ccb87e8eb0ef6a6 | OPP-7600dc623b17b6c4b94951f111f8fb05aee8b292ed9ffacc2f82148d5bf43c6a | SER-4226f1321281b926921bf753bdb53faf54fc121c4378d870eee7f18a25812ec8 | — | **** | — | — | Copperfield Laboratory Partners, Corp. | 44663 | HQ | — | NY | — | — | — | Beckman Access / DxI | — | — | — | — | — | 3 completed purchases over 221 days; median interval 110.5 days; expected reorder 2026-05-17; High Risk by 85 days. | — | 176 | — | — | 91 | — | 55.6 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-c9addcd48778b1ee99a7fb76b2efa5ad95bd581f43b29d538ccb87e8eb0ef6a6 | Customer 44663 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-353d6df8208aaf3acffdb2fab8f690bdb7d7196a57c1e9b924aed261b5d56c09 | OPP-cea5b243216c2b543f8ba62adf06294c4f45c0ac2ac03b9bb131ba3da3bb3dd6 | SER-2c96947ff24e58732f432df6cd62e910e373e6853d0fdf0950ce023782ffe0eb | — | **** | — | — | Copperfield Laboratory Partners, Corp. | 44663 | HQ | — | NY | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 6 completed purchases over 409 days; median interval 67.0 days; expected reorder 2026-09-09; Due Soon in 30 days. | — | 195 | — | — | 136.95 | — | 51.81 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-353d6df8208aaf3acffdb2fab8f690bdb7d7196a57c1e9b924aed261b5d56c09 | Customer 44663 |